2. Gene
  3. CALY - calcyon neuron specific vesicular protein Gene

CALY - calcyon neuron specific vesicular protein Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens

Also known as NSG3; DRD1IP

Gene ID: 50632 | Gene type: protein coding

About CALY

Cytogenetic location: 10q26.3 Genomic coordinates (GRCh38): 10:133,324,072-133,336,896 (from NCBI)

This gene has 5 transcripts (splice variants), 169 orthologues and 2 paralogues. Biased expression in brain (RPKM 10.6), adrenal (RPKM 3.4) and 1 other tissue.

Summary

The protein encoded by this gene is a type II single transmembrane protein. It is required for maximal stimulated calcium release after stimulation of purinergic or muscarinic but not beta-adrenergic receptors. The encoded protein interacts with D1 Dopamine Receptor and may interact with Other DA receptor subtypes and/or GPCRs. [provided by RefSeq, Jul 2008]

CALY Products(2)

mRNA Protein Name
NM_001321617.2 NP_001308546.1 neuron-specific vesicular protein calcyon isoform 2
NM_015722.4 NP_056537.1 neuron-specific vesicular protein calcyon isoform 1
Gene Ontology
  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence Reference Source
enables clathrin light chain binding IDA
IDA: Inferred from direct assay
16595675 GOA
enables protein binding IPI
IPI: Inferred from physical interaction
16595675 GOA
Biological Process GO Annotation Evidence Reference Source
involved in clathrin coat assembly IDA
IDA: Inferred from direct assay
16595675 GOA
involved in positive regulation of endocytosis IMP
IMP: Inferred from mutant phenotype
16595675 GOA
Cellular Component GO Annotation Evidence Reference Source
located in cytoplasmic vesicle IDA
IDA: Inferred from direct assay
14534309 GOA
located in plasma membrane IDA
IDA: Inferred from direct assay
14534309 GOA
is active in postsynaptic endocytic zone IDA
IDA: Inferred from direct assay
16595675 GOA
is active in postsynaptic endocytic zone IMP
IMP: Inferred from mutant phenotype
16595675 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

CALY Protein Structure

Calcyon

Calcyon: D1 dopamine receptor-interacting protein (calcyon) (1 - 197)

  • 0
  • 100
  • 200
  • 217 a.a.
Protein Preferred Names Protein Names

neuron-specific vesicular protein calcyon

D1 dopamine receptor-interacting protein

CALY Protein-protein interaction Information

Type
Protein Name Protein ID Interactor Interactor Species Interactor ID Detection Method Reference
Intra
CALY Q9NYX4 CLTA Homo sapiens P09496
Anti Tag CoIP
16595675
Cross: Cross-species interaction Intra: Intraspecies interaction

Related Diseases

Diseases Alias
Childhood Pilocytic Astrocytoma

Pediatric Pilocytic Astrocytoma
Glutaric Aciduria Iii

Glutaryl-Coa Oxidase Deficiency

Ga Iii

Glutaric Acidemia Type 3

GA3

Glutaric Aciduria Type 3

Glutaric Aciduria 3

Glutaric Acidemia Type Iii

Glutaric Aciduria Type Iii
Malignant Essential Hypertension

Accelerated Essential Hypertension
Schizophrenia

SCZD

Schizophrenia With Or Without An Affective Disorder

Schizophrenia 12

Schizophrenia, Susceptibility To

Schizophrenia-1

Dementia Praecox

Schizophrenia 1
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Approval
Bioactive Molecules (80)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-15244 Alpelisib Inhibitor 99.95% Yes
HY-10341 Fasudil Hydrochloride 99.96% Yes
HY-N0215 L-Phenylalanine Antagonist 99.96% Unkown
HY-B0246 Carbamazepine 99.95% Yes
HY-13764 Tetrandrine Inhibitor 99.91% Yes
HY-B0782 Acetazolamide 99.89% Yes
HY-A0057 Gabapentin Inhibitor ≥98.0% Yes
HY-B0561 Spironolactone 99.66% Yes
HY-70037 Cinacalcet Agonist 99.97% Yes
HY-B0193A Prazosin hydrochloride 99.86% Unkown
HY-12542 Dantrolene Inhibitor ≥98.0% Yes
HY-B1221 Flufenamic acid 99.93% Unkown
HY-14656 Diltiazem hydrochloride Antagonist 99.04% Yes
HY-B1193 Terfenadine 99.91% Unkown
HY-75161 (-)-Menthol Activator 99.79% Unkown
HY-15553A Mibefradil dihydrochloride Inhibitor ≥98.0% Unkown
HY-70037A Cinacalcet hydrochloride Agonist 99.99% Yes
HY-17404 Cilnidipine Inhibitor 99.72% Yes
HY-N1370 Tanshinone IIA sulfonate sodium Inhibitor 99.77% Unkown
HY-B1077 Penfluridol 99.93% Unkown
HY-B1546A Benzamil hydrochloride Inhibitor 99.80% Unkown
HY-B0358A Flunarizine dihydrochloride 99.87% Yes
HY-B0596 Taltirelin 99.86% Unkown
HY-17613 Evocalcet Activator 98.39% Unkown
HY-12542A Dantrolene sodium hemiheptahydrate Inhibitor 99.79% Yes
HY-B0632 Diltiazem Inhibitor 99.70% Yes
HY-N1369 Menthol Modulator / Unkown
HY-B0782A Acetazolamide sodium 99.66% Yes
HY-10932 Aniracetam Modulator 99.89% Unkown
HY-75839 Dronedarone Hydrochloride 99.99% Unkown
HY-B1671 (+)-Kavain 99.98% Unkown
HY-A0082 Diphenidol hydrochloride Antagonist 99.95% Unkown
HY-B1693 Levomepromazine 99.98% Unkown
HY-B0358 Flunarizine 99.93% Yes
HY-B1424 Benzthiazide Inhibitor 99.70% Unkown
HY-B0109A Dorzolamide hydrochloride Inhibitor 99.92% Yes
HY-B0588 Brinzolamide Inhibitor 99.61% Unkown
HY-B0021 Doxifluridine Inhibitor 99.91% Unkown
HY-14657 Dantrolene sodium Inhibitor ≥98.0% Yes
HY-A0057A Gabapentin hydrochloride Inhibitor ≥98.0% Yes
HY-B0684 Iopamidol 99.81% Unkown
HY-103370 Talniflumate Inhibitor 99.67% Yes
HY-Y0258A Benzocaine hydrochloride 99.31% Unkown
HY-Z0478 (-)-Limonene Inhibitor ≥95.0% Unkown
HY-B1471 Fluorometholone acetate Inhibitor 98.54% Unkown
HY-121186 Bevantolol hydrochloride Antagonist 98.98% Yes
HY-B0473 Tetracaine hydrochloride Inhibitor 99.91% Unkown
HY-16952A Bepridil hydrochloride hydrate Antagonist 99.73% Unkown
HY-U00212 Aranidipine Antagonist 99.12% Unkown
HY-107319 Almitrine mesylate Inhibitor 99.81% Unkown
HY-B0562 Methyclothiazide 99.76% Unkown
HY-A0135 Enflurane Inhibitor ≥98.0% Unkown
HY-P1769 Angiotensin II (5-8), human 99.68% Unkown
HY-B0246R Carbamazepine (Standard) / Unkown
HY-109545 Isopropyl unoprostone Activator 95.1% Unkown
HY-B0596A Taltirelin acetate 98.77% Unkown
HY-10341A Fasudil / Unkown
HY-15553 Mibefradil Inhibitor / Unkown
HY-B0109 Dorzolamide Inhibitor / Unkown
HY-10341B Fasudil hydrochloride semihydrate / Unkown
HY-10341C Fasudil dihydrochloride / Unkown
HY-12882 Ifenprodil / Unkown
HY-116790 (-)-Penbutolol Antagonist / Unkown
HY-121166 Levobetaxolol Antagonist / Unkown
HY-128370 Calcium trinatrium diethylenetriaminepentaacetic acid hydrate Inhibitor ≥98.0% Unkown
HY-14656R Diltiazem hydrochloride (Standard) Antagonist / Unkown
HY-156787 Porfimer sodium / Unkown
HY-75839R Dronedarone Hydrochloride (Standard) / Unkown
HY-A0270 Diphenidol Antagonist / Unkown
HY-B0021R Doxifluridine (Standard) Inhibitor / Unkown
HY-B0109AR Dorzolamide hydrochloride (Standard) Inhibitor / Unkown
HY-B0193AR Prazosin hydrochloride (Standard) / Unkown
HY-B0401A Tolbutamide sodium Inducer / Unkown
HY-B0588A Brinzolamide hydrochloride Inhibitor / Unkown
HY-B0588R Brinzolamide (Standard) Inhibitor / Unkown
HY-B1546 Benzamil Inhibitor / Unkown
HY-B1558 Bifemelane / Unkown
HY-P1792 Angiotensin II (1-4), human Agonist / Unkown
HY-P1792A Angiotensin II (1-4), human TFA Agonist / Unkown
HY-B1693R Levomepromazine (Standard) / Unkown
Clinical Phase
Bioactive Molecules (58)
Cat. No. Product Name Effect
Purity Phase
HY-N6687 Calcimycin 99.12% Phase 4
HY-100560 Abscisic acid Inhibitor 99.72% Phase 4
HY-N6687A Calcimycin hemicalcium salt / Phase 4
HY-N6687B Calcimycin hemimagnesium / Phase 4
HY-13898 Taselisib Inhibitor 99.75% Phase 3
HY-50694 Senicapoc Inhibitor 99.88% Phase 3
HY-17449 Fosbretabulin disodium 99.47% Phase 3
HY-10805 Almorexant 99.71% Phase 3
HY-18256 Ombrabulin hydrochloride Inhibitor 99.57% Phase 3
HY-10805A Almorexant hydrochloride 99.98% Phase 3
HY-14797 Ombrabulin Inhibitor 98.00% Phase 3
HY-Z7721 (Rac)-Beraprost sodium Inhibitor / Phase 3
HY-N1584 Halofuginone 99.92% Phase 2
HY-135317 Emavusertib 99.94% Phase 2
HY-13513 U-104 Inhibitor 99.95% Phase 2
HY-10007 NPS-2143 Antagonist 99.33% Phase 2
HY-N1584A Halofuginone hydrobromide 99.99% Phase 2
HY-10167A Tecalcet Hydrochloride Modulator 99.66% Phase 2
HY-15724 Vercirnon Antagonist 98.26% Phase 2
HY-115864 Osavampator Activator 99.89% Phase 2
HY-15293B JTV-519 hemifumarate Inhibitor 98.69% Phase 2
HY-100414 Soraprazan Inhibitor 99.54% Phase 2
HY-123205 Oxatomide 99.56% Phase 2
HY-100779 Rimacalib Inhibitor 99.14% Phase 2
HY-118467 Benzolamide Inhibitor 99.07% Phase 2
HY-19721 ABT-639 Inhibitor 99.32% Phase 2
HY-15724A Vercirnon sodium Antagonist 99.13% Phase 2
HY-10066 Nelivaptan Antagonist 98.35% Phase 2
HY-147301 Resomelagon Agonist 99.63% Phase 2
HY-108232 MK-2206 / Phase 2
HY-100298 Caldaret Inhibitor 98.35% Phase 2
HY-137459 Vocacapsaicin Agonist / Phase 2
HY-15293A JTV-519 free base Inhibitor / Phase 2
HY-135317B Emavusertib hydrochloride Inhibitor / Phase 2
HY-10357 MK-2206 free base / Phase 2
HY-100934 SC-9 Activator / Phase 2
HY-110312 JTV-519 fumarate / Phase 2
HY-121535 Levosemotiadil Inhibitor / Phase 2
HY-137459A Vocacapsaicin hydrochloride Antagonist / Phase 2
HY-169115 PD-0299685 / Phase 2
HY-101616 ABT-639 hydrochloride Inhibitor / Phase 2
HY-106415 Terflavoxate Antagonist / Phase 2
HY-106904 Nexopamil Antagonist / Phase 2
HY-106927 Bay Y5959 Agonist / Phase 2
HY-114826S Prostaglandin E2-1-glyceryl ester-d5 Activator / Phase 2
HY-108496 Sphingosine-1-phosphate Agonist ≥99.0% Phase 1
HY-100973A Adenosine 5′-diphosphoribose sodium 99.03% Phase 1
HY-153306 RLY-2608 Inhibitor 99.20% Phase 1
HY-101093 CA-170 Inhibitor 99.39% Phase 1
HY-129851 NTP42 Antagonist 98.02% Phase 1
HY-100886 BAY1082439 98.02% Phase 1
HY-120588 BI 639667 Antagonist 99.47% Phase 1
HY-16935 Mavatrep Antagonist 99.60% Phase 1
HY-115681 (2R/S)-6-PNG Inhibitor 99.88% Phase 1
HY-133011 nAChR agonist 1 Agonist 98.35% Phase 1
HY-137458 Vevorisertib Inhibitor / Phase 1
HY-118148 UK-66914 Inhibitor / Phase 1
HY-121701 SR33805 analog Antagonist / Phase 1
Pre-clinical Phase
Bioactive Molecules (677)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-13433 Thapsigargin 99.95% Unkown
HY-13434 Ionomycin ≥99.0% Unkown
HY-18723 Yoda 1 99.98% Unkown
HY-100545 BAPTA-AM Inhibitor 99.68% Unkown
HY-W009724 2-Aminoethyl diphenylborinate 99.86% Unkown
HY-D0861 EGTA ≥98.0% Unkown
HY-101896 Fluo-4 AM ≥99.0% Unkown
HY-N0219 Bicuculline Antagonist 99.97% Unkown
HY-D0989 Rhod-2 AM ≥97.0% Unkown
HY-19608 GSK1016790A 99.79% Unkown
HY-100202 TPEN 99.69% Unkown
HY-P2149 Concanavalin A Inducer / Unkown
HY-100168 BAPTA Inhibitor 98.10% Unkown
HY-13434A Ionomycin calcium ≥98.0% Unkown
HY-126010 Dooku1 Antagonist 99.93% Unkown
HY-100350 CA-074 methyl ester Inhibitor 99.62% Unkown
HY-10588 Bay K 8644 Agonist 99.96% Unkown
HY-103350 CA-074 Inhibitor 99.88% Unkown
HY-134923 CA77.1 Inducer 99.98% Unkown
HY-100831 YM-58483 Inhibitor 99.38% Unkown
HY-118630 Vacuolin-1 Inhibitor 98.93% Unkown
HY-12323 ISX-9 Activator 98.90% Unkown
HY-101455 CDN1163 Activator 99.89% Unkown
HY-15754 CGP37157 Inhibitor 99.50% Unkown
HY-138620 MCU-i4 Inhibitor 99.87% Unkown
HY-100912 W-7 hydrochloride 99.96% Unkown
HY-131614 TPC2-A1-N Inhibitor 99.86% Unkown
HY-119287 TSQ 99.88% Unkown
HY-100001 SKF-96365 hydrochloride 99.91% Unkown
HY-113308A Taurolithocholic acid sodium salt Agonist 99.81% Unkown
HY-101379A 8-Bromo-cGMP sodium Inhibitor 99.58% Unkown
HY-120691A GSK205 Antagonist 99.47% Unkown
HY-N6732 K-252a Inhibitor 99.45% Unkown
HY-19805 STO-609 Inhibitor 98.13% Unkown
HY-103312 Xestospongin C Inhibitor ≥90.0% Unkown
HY-103319 Calmidazolium chloride Antagonist 99.69% Unkown
HY-P0256 Apamin Inhibitor 99.71% Unkown
HY-123071A Box5 TFA Antagonist 94.71% Unkown
HY-108465 Pyr3 Inhibitor 99.90% Unkown
HY-101897 Fura-2 AM ≥99.0% Unkown
HY-116522 AR420626 98.29% Unkown
HY-D1024 Coelenterazine h 98.02% Unkown
HY-D1498 Mag-Fluo-4 AM ≥96.0% Unkown
HY-N0215S12 L-Phenylalanine-d5 Antagonist 99.15% Unkown
HY-D0716 Fluo-3AM ≥99.0% Unkown
HY-108599 DCP-LA ≥98.0% Unkown
HY-15415 KB-R7943 mesylate Inhibitor 99.16% Unkown
HY-N6778 Paxilline Inhibitor 99.83% Unkown
HY-12949 ML204 Inhibitor 99.08% Unkown
HY-15124 (S)-(-)-Bay-K-8644 Agonist 98.81% Unkown
HY-116330A Hyperforin dicyclohexylammonium salt 99.52% Unkown
HY-135897 Urolithin C ≥98.0% Unkown
HY-15515 SEA0400 Inhibitor 99.96% Unkown
HY-D0973 EGTA-AM ≥90.0% Unkown
HY-101906 DC260126 99.74% Unkown
HY-116429 Maresin 1 Inhibitor 99.00% Unkown
HY-N0043 Ginsenoside Rd Inhibitor 99.88% Unkown
HY-101017 Palmitoylcarnitine chloride ≥98.0% Unkown
HY-N6789 KT5720 Inhibitor ≥99.0% Unkown
HY-P3278A Caloxin 2A1 TFA Inhibitor 99.96% Unkown
HY-119401 CAY10444 Antagonist ≥98.0% Unkown
HY-19408 Pyr10 Inhibitor 99.42% Unkown
HY-101044 PPADS tetrasodium ≥95.0% Unkown
HY-16697 CID 16020046 Antagonist 99.87% Unkown
HY-107543 8-CPT-2Me-cAMP sodium Activator 99.58% Unkown
HY-110105 NS8593 hydrochloride Inhibitor 99.81% Unkown
HY-107411 Bromoenol lactone Inhibitor 98.41% Unkown
HY-120261 GB-88 Inhibitor 99.05% Unkown
HY-N0252 Catharanthine Inhibitor 99.65% Unkown
HY-133168 Englerin A Activator 99.50% Unkown
HY-107658 SN 6 Inhibitor 99.79% Unkown
HY-111208 CCT129957 Inhibitor 99.71% Unkown
HY-15416 NS309 Activator 99.09% Unkown
HY-120528A GB-110 hydrochloride Agonist 99.86% Unkown
HY-12496 NS-1619 98.06% Unkown
HY-126750 GNF362 Inhibitor 99.63% Unkown
HY-100168B BAPTA tetrapotassium Inhibitor 99.45% Unkown
HY-103307 FPL64176 Agonist 99.81% Unkown
HY-124171 Zinquin ethyl ester ≥99.0% Unkown
HY-103309 ML218 Inhibitor 99.49% Unkown
HY-N0515 Ophiopogonin D 99.54% Unkown
HY-120072 PF-3450074 Inhibitor 98.44% Unkown
HY-14229 TGR5 Receptor Agonist Agonist 99.71% Unkown
HY-P1345A TLQP-21 TFA Agonist 99.90% Unkown
HY-Y0413 Biacetyl monoxime Inhibitor ≥98.0% Unkown
HY-N2549 (±)-Abscisic acid Inducer 99.91% Unkown
HY-103306 Ryanodine Inhibitor 99.35% Unkown
HY-103660 18:0 LYSO-PE ≥99.0% Unkown
HY-160187 AAA 98.10% Unkown
HY-W048457 Palladium hydroxide on activated carbon(20%)(wetted with ca. 55% Water) Control / Unkown
HY-103320A Calhex 231 hydrochloride Inhibitor 99.81% Unkown
HY-103474 Bicuculline methiodide Inhibitor 99.24% Unkown
HY-N0607 Ginsenoside Ro 99.81% Unkown
HY-112698 CA-5f 99.14% Unkown
HY-114252 Strophanthidin Inhibitor 92.66% Unkown
HY-121119 MRS 1523 99.93% Unkown
HY-123071 Box5 Antagonist 98.32% Unkown
HY-P1080A ω-Agatoxin IVA TFA Inhibitor 98.13% Unkown
HY-101360 1-EBIO Agonist 99.96% Unkown
HY-D1903 Fura Red AM 91.00% Unkown
HY-157131 TRPV2-selective blocker 1 Inhibitor 99.84% Unkown
HY-10171 NPS-2143 hydrochloride Antagonist 99.80% Unkown
HY-110153 NS19504 Activator 99.93% Unkown
HY-15084B Dizocilpine Antagonist 99.90% Unkown
HY-16992A W-54011 ≥98.0% Unkown
HY-16689 VU 0240551 Inhibitor 99.97% Unkown
HY-N0084 Betulinaldehyde Inhibitor 98.72% Unkown
HY-N0601 Ginsenoside Rf Inhibitor 99.48% Unkown
HY-110243 CAIX Inhibitor S4 Inhibitor 99.04% Unkown
HY-124873 SERCA2a activator 1 Activator 99.71% Unkown
HY-14350 AC-55541 Agonist 99.25% Unkown
HY-149662 TMDJ-035 Inhibitor 99.44% Unkown
HY-16690 BTS Inhibitor 99.74% Unkown
HY-N0215S1 L-Phenylalanine-d8 Antagonist 99.62% Unkown
HY-I0096 Indole-2-carboxylic acid Inhibitor 99.86% Unkown
HY-N2344 Procyanidin A1 Inhibitor 99.19% Unkown
HY-P1821A Myelin Basic Protein TFA 97.35% Unkown
HY-W194810 MCU-i11 98.42% Unkown
HY-100168A BAPTA tetrasodium Inhibitor 99.70% Unkown
HY-114400 TRPV4 agonist-1 free base Agonist 99.58% Unkown
HY-101015A OBAA 99.27% Unkown
HY-124416 ML604086 Inhibitor 99.80% Unkown
HY-145542 Isovalerylcarnitine chloride Activator ≥98.0% Unkown
HY-15671 GKA50 Activator 99.57% Unkown
HY-N4104 Agaric acid Activator 99.57% Unkown
HY-P0190A Iberiotoxin TFA Inhibitor 99.67% Unkown
HY-108593 BMS-191011 Activator 99.12% Unkown
HY-13103 NS 11021 Activator 99.51% Unkown
HY-P1366 des-​Gln14-​Ghrelin 98.61% Unkown
HY-16639 ML314 Agonist 99.52% Unkown
HY-12504 Pyr6 Inhibitor 98.47% Unkown
HY-I1070 D-Isoleucine ≥98.0% Unkown
HY-N7690 3,5,7,3′,4′-Pentamethoxyflavone Inhibitor 99.15% Unkown
HY-P1845 PACAP-38 (31-38), human, mouse, rat Inducer 99.98% Unkown
HY-P1845A PACAP-38 (31-38), human, mouse, rat TFA Inducer 98.33% Unkown
HY-W131725 (+)-Norfenfluramine Agonist / Unkown
HY-33299 Serpin B9-IN-1 ≥97.0% Unkown
HY-101396 ICA-069673 Activator 99.65% Unkown
HY-103316A Ned 19 Inhibitor 99.92% Unkown
HY-118010A (+)-Norfenfluramine hydrochloride Agonist 99.77% Unkown
HY-15292 S107 Ligand 99.77% Unkown
HY-162501 Yaddle1 Agonist 99.14% Unkown
HY-P0190 Iberiotoxin Inhibitor 98.63% Unkown
HY-W001538 S-Propargylcysteine ≥97.0% Unkown
HY-W019981C Magnesium chloride hexahydrate, for cell culture Activator / Unkown
HY-12949A ML204 hydrochloride Inhibitor 99.74% Unkown
HY-108607 PACOCF3 Inhibitor ≥98.0% Unkown
HY-12927 SX-517 Antagonist 99.88% Unkown
HY-136460 Calcium ionophore I ≥99.0% Unkown
HY-136909 SR33805 Antagonist 99.19% Unkown
HY-N7063 Nerol 98.97% Unkown
HY-P0256A Apamin TFA Inhibitor 98.35% Unkown
HY-P1076A CALP2 TFA Antagonist 99.79% Unkown
HY-P1077A CALP1 TFA 98.30% Unkown
HY-12498 GV-58 Agonist 99.22% Unkown
HY-104058 Oregon-BAPTA Green 1AM 92.0% Unkown
HY-135746 OR-1896 99.03% Unkown
HY-135891 AZD2423 Antagonist 99.91% Unkown
HY-P3965 16-38-Thymosin β4 (cattle) Activator 98.14% Unkown
HY-W181102 NFAT Inhibitor-2 Inhibitor 98.02% Unkown
HY-157453 CCR4 antagonist 4 Antagonist 99.72% Unkown
HY-137175 TMBIM6 antagonist-1 Antagonist 99.60% Unkown
HY-101329 Anthracene-9-carboxylic acid Inhibitor 99.09% Unkown
HY-103277A BIM 23042 TFA Antagonist 96.20% Unkown
HY-10388 TTA-Q6 Antagonist 99.97% Unkown
HY-125703 Ferutinin 99.23% Unkown
HY-129440 N-(p-Coumaroyl) Serotonin Inhibitor 99.03% Unkown
HY-136190 TRPC6-PAM-C20 Agonist 99.78% Unkown
HY-136409 N-Decanoyl-L-homoserine lactone 99.43% Unkown
HY-145127 ETZ 97.06% Unkown
HY-162426 UNC-CA2-103 99.26% Unkown
HY-B0782R Acetazolamide (Standard) 99.69% Unkown
HY-D1024A Coelenterazine h hydrochloride 98.80% Unkown
HY-N0215S8 L-Phenylalanine-13C6 Antagonist ≥99.0% Unkown
HY-N2500 Deoxypodophyllotoxin 99.87% Unkown
HY-41076 Ca2+ channel agonist 1 99.71% Unkown
HY-111207 CA224 99.94% Unkown
HY-100783 (-)-Bicuculline methobromide Antagonist ≥99.0% Unkown
HY-101087 Benzenesulphonamide Inhibitor 99.51% Unkown
HY-101366 A-61603 Agonist ≥99.0% Unkown
HY-106844A (+)-EMD 57033 99.72% Unkown
HY-108464A Phenamil methanesulfonate Inhibitor ≥98.0% Unkown
HY-108592 UCL 2077 Inhibitor 98.91% Unkown
HY-116291 4α-Phorbol 12,13-didecanoate Agonist 99.30% Unkown
HY-120026 KB130015 Inhibitor 98.28% Unkown
HY-124594 CA inhibitor 1 Inhibitor 99.94% Unkown
HY-P0271A Syntide 2 TFA 98.26% Unkown
HY-P4160 PDC31 Inhibitor 99.76% Unkown
HY-107855S DL-Mevalonolactone-d7 ≥99.0% Unkown
HY-108608 o-3M3FBS 99.88% Unkown
HY-126077 MTI-31 Inhibitor 99.98% Unkown
HY-136182 YM-244769 dihydrochloride Inhibitor 99.02% Unkown
HY-A0236A Aprindine hydrochloride Inhibitor 98.96% Unkown
HY-D0202 Arsenazo III ≥95.0% Unkown
HY-E70200 Recombinant Kex2 protease / Unkown
HY-N0215S3 L-Phenylalanine-d2 Antagonist 99.89% Unkown
HY-N0215S5 L-Phenylalanine-15N Antagonist 98.10% Unkown
HY-N0385 Gomisin J Activator 99.84% Unkown
HY-N2060 Evocarpine 99.73% Unkown
HY-P3089A Dendrotoxin K TFA Inhibitor ≥98.0% Unkown
HY-W111226 Fmoc-His(3-Me)-OH Inhibitor ≥98.0% Unkown
HY-W010451 1,2,4-Trihydroxybenzene Activator 99.12% Unkown
HY-103308 TRAM-39 Inhibitor 99.66% Unkown
HY-103317 NAADP 95.8% Unkown
HY-103442 CGP52411 Inhibitor 99.82% Unkown
HY-11000A CaMKP inhibitor sodium Inhibitor 98.06% Unkown
HY-120597 SAK3 Activator 99.44% Unkown
HY-128678 ORM-10103 Inhibitor 99.97% Unkown
HY-13338 Mabuterol Agonist 99.96% Unkown
HY-136182A YM-244769 Inhibitor 98.04% Unkown
HY-146268 CaMKIIα-IN-1 Inhibitor 98.41% Unkown
HY-161104 Kv2.1-IN-1 Inhibitor 98.64% Unkown
HY-32933 4-Acetylphenylboronic acid Inhibitor 99.96% Unkown
HY-D0110A Fura-2 pentapotassium ≥97.0% Unkown
HY-N0081 (±)-Praeruptorin A Inhibitor 99.94% Unkown
HY-N0215S7 L-Phenylalanine-3-13C Antagonist 99.48% Unkown
HY-N1940 β-Anhydroicaritin Inhibitor 99.09% Unkown
HY-N5130 Effusol Inhibitor 99.83% Unkown
HY-P1075 CALP3 Inhibitor 98.57% Unkown
HY-P1247 Calcineurin autoinhibitory peptide Inhibitor 99.96% Unkown
HY-P1250 RFRP-3(human) Agonist 99.21% Unkown
HY-P1397A RVD-Hpα TFA Agonist 99.32% Unkown
HY-P1479A Calmodulin-Dependent Protein Kinase II(290-309) acetate 98.45% Unkown
HY-P5914A Wasabi Receptor Toxin TFA Activator 99.49% Unkown
HY-W074975 CL 5343 Inhibitor ≥98.0% Unkown
HY-100402 CFMTI Antagonist ≥98.0% Unkown
HY-101428 NS-638 Inhibitor 99.84% Unkown
HY-101693A Senazodan hydrochloride Inhibitor 99.84% Unkown
HY-103320B (1R,2R)-Calhex 231 hydrochloride 99.07% Unkown
HY-103472 FPR-A14 Agonist 99.90% Unkown
HY-10388A TTA-Q6(isomer) 99.84% Unkown
HY-108496S Sphingosine-1-phosphate-d7 Agonist 99.00% Unkown
HY-117073 ITH12575 Inhibitor 99.14% Unkown
HY-121604 (Rac)-MEM 1003 Inhibitor 99.64% Unkown
HY-13699 NBI-42902 98.65% Unkown
HY-137790 Bicuculline methochloride Antagonist 99.35% Unkown
HY-147301A Resomelagon acetate Agonist 99.75% Unkown
HY-149301 hCAIX-IN-18 Inhibitor 98.52% Unkown
HY-155516 KV1.3-IN-1 Inhibitor 98.34% Unkown
HY-15705 GPR35 agonist 2 98.84% Unkown
HY-B0493S1 Niflumic acid-13C6 Inhibitor 99.8% Unkown
HY-D0121A INDO 1 pentapotassium ≥95.0% Unkown
HY-N0215S11 L-Phenylalanine-13C9,15N Antagonist 99.52% Unkown
HY-N0215S14 L-Phenylalanine-15N,d8 Antagonist 99.90% Unkown
HY-N0215S2 L-Phenylalanine-13C Antagonist 99.66% Unkown
HY-N0252A Catharanthine Tartrate Inhibitor 98.88% Unkown
HY-N6701 Dihydrocytochalasin B 94.86% Unkown
HY-N7575 Lacto-N-fucopentaose II ≥98.0% Unkown
HY-NP009 α-Lactalbumin 100.00% Unkown
HY-P5154A Tamapin TFA Antagonist 98.79% Unkown
HY-P5189A His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA 99.31% Unkown
HY-W013857 Lavendustin C Inhibitor 98.32% Unkown
HY-W041308 DCOIT Agonist 99.74% Unkown
HY-126789A DM-Nitrophen tertasodium ≥90.0% Unkown
HY-150135B D-myo-Inositol 1,4,5-trisphosphate tripotassium Activator 98.00% Unkown
HY-105118A Zaldaride maleate Antagonist ≥98.0% Unkown
HY-160023 D3S-001 Inhibitor / Unkown
HY-101902 Quin-2AM / Unkown
HY-N0215S L-Phenylalanine-d7 Antagonist 99.90% Unkown
HY-100718 SCH00013 / Unkown
HY-101015 (2E)-OBAA / Unkown
HY-101329S Anthracene-9-carboxylic acid-d9 98.94% Unkown
HY-104056 Fura Red / Unkown
HY-106784A (E)-Ajoene / Unkown
HY-107659 YM-244769 hydrochloride Inhibitor 99.02% Unkown
HY-107678 SEN12333 Agonist 98.45% Unkown
HY-113970A Nebracetam hydrochloride Agonist ≥99.0% Unkown
HY-115745 Calmodulin antagonist-1 Antagonist ≥98.0% Unkown
HY-119282 AZD6538 Inhibitor / Unkown
HY-120514 JNc-440 98.04% Unkown
HY-120528 GB-110 Agonist / Unkown
HY-121584 Lycoperodine-1 Agonist 99.82% Unkown
HY-12550 GW542573X Activator 98.79% Unkown
HY-126583 Nemadipine-A Inhibitor 98.0% Unkown
HY-129496 NP-313 Inhibitor 99.58% Unkown
HY-131040 NLRP3-IN-NBC6 Inhibitor 99.40% Unkown
HY-13617 Edatrexate / Unkown
HY-136395 Cartap Inducer / Unkown
HY-145384 ROC-0929 Inhibitor 99.48% Unkown
HY-147005 piCRAC-1 Inhibitor 98.24% Unkown
HY-147384 CXL-1020 ≥99.0% Unkown
HY-148135 hCAI/II-IN-6 Inhibitor ≥98.0% Unkown
HY-151916 Enpp/Carbonic anhydrase-IN-1 99.57% Unkown
HY-155480 PSB-22034 Agonist / Unkown
HY-15671A GKA50 quarterhydrate Activator ≥98.0% Unkown
HY-16147 Combretastatin A1 phosphate 98.00% Unkown
HY-163796 GPR183-IN-2 Inhibitor 99.90% Unkown
HY-16489A Terodiline hydrochloride Antagonist 99.78% Unkown
HY-76779 4-(Chloromethyl)-7-hydroxycoumarin 97.96% Unkown
HY-B0782S Acetazolamide-d3 Inhibitor 99.95% Unkown
HY-B1221S1 Flufenamic acid-13C6 / Unkown
HY-N0215S10 L-Phenylalanine-13C9 Antagonist 98% Unkown
HY-N0252B Catharanthine Sulfate Inhibitor / Unkown
HY-N10772 Albanin A Inhibitor 97.67% Unkown
HY-N1584C Halofuginone lactate 98.32% Yes
HY-N2359 Chelerythrine / Unkown
HY-N4267 Yangambin Inhibitor 98.27% Unkown
HY-N6688 Verruculogen Inhibitor 97.52% Unkown
HY-P0271 Syntide 2 / Unkown
HY-P1079 ω-Agatoxin TK Inhibitor ≥99.0% Unkown
HY-P1387 β-Amyloid (1-40) (rat) Inducer / Unkown
HY-P3037 Imperatoxin A Activator / Unkown
HY-P3278 Caloxin 2A1 Inhibitor 99.82% Unkown
HY-P3811A Autocamtide-3 acetate 99.62% Unkown
HY-P3965A 16-38-Thymosin β4 (cattle) (TFA) Activator 98.14% Unkown
HY-P5914 Wasabi Receptor Toxin Activator / Unkown
HY-P5988 N-myristoyl-RKRTLRRL Inhibitor 99.37% Unkown
HY-RS10523 PIK3CA Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-100928 YS 035 hydrochloride Antagonist 99.15% Unkown
HY-101693 Senazodan Inhibitor / Unkown
HY-113040A (17R,18S)-Epoxyeicosatetraenoic acid Inhibitor ≥93.0% Unkown
HY-126789 DM-Nitrophen / Unkown
HY-12962 NMDA-IN-1 Antagonist 98.98% Unkown
HY-131948 3-Chlorodiphenylamine Activator 98.74% Unkown
HY-70037AS Cinacalcet-d3 hydrochloride Agonist 97.63% Unkown
HY-N0742 Absinthin Agonist ≥98.0% Unkown
HY-N7491A Ent-(+)-Verticilide Inhibitor 99.91% Unkown
HY-P3037A Imperatoxin A TFA Activator 98.65% Unkown
HY-B0109AS1 Dorzolamide-d5(hydrochloride) Inhibitor / Unkown
HY-114400A TRPV4 agonist-1 Agonist / Unkown
HY-102085 11-Deoxyglycyrrhetinic acid sodium Activator / Unkown
HY-103309A ML218 hydrochloride Inhibitor / Unkown
HY-125836 CCR4 antagonist 2 Antagonist / Unkown
HY-19805A STO-609 acetate Inhibitor / Unkown
HY-N1584B Halofuginone hydrochloride / Unkown
HY-14656S Diltiazem-d3 hydrochloride Antagonist 98.46% Unkown
HY-B0632S Diltiazem-d6 Antagonist / Unkown
HY-N1369S Menthol-d4 / Unkown
HY-P2471 Neurogranin (48-76), mouse Inhibitor / Unkown
HY-100783A (+)-Bicuculline methochloride Antagonist / Unkown
HY-100783B Bicuculline methobromide Antagonist / Unkown
HY-100843 L-AP6 / Unkown
HY-101685A Iganidipine di(hydrochloride) Antagonist / Unkown
HY-103078 I-XW-053 Inhibitor 99.71% Unkown
HY-103078A I-XW-053 sodium Inhibitor / Unkown
HY-103277 BIM 23042 Antagonist / Unkown
HY-103309S ML218-d9 Inhibitor / Unkown
HY-103313 SR33805 oxalate Antagonist / Unkown
HY-103320 Calhex 231 Antagonist / Unkown
HY-103544 [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P / Unkown
HY-105118 Zaldaride Inhibitor / Unkown
HY-106428 Icrocaptide Inhibitor / Unkown
HY-106761 Oxodipine Antagonist / Unkown
HY-106818A Monatepil maleate / Unkown
HY-106837 Israpafant Antagonist / Unkown
HY-107855S1 DL-Mevalonolactone-d3 / Unkown
HY-108163A SB-237376 / Unkown
HY-110140 (E)-KN-93 phosphate Inhibitor 99.85% Unkown
HY-111014 VK-II-36 Activator 99.63% Unkown
HY-111214 K-14585 / Unkown
HY-112393 TX-1918 Inhibitor / Unkown
HY-112741 SB-209247 Antagonist / Unkown
HY-112794 Topanol CA / Unkown
HY-113308AS Taurolithocholic acid-d4 sodium Agonist / Unkown
HY-113308AS1 Taurolithocholic Acid-d5 sodium salt Agonist / Unkown
HY-113308AS2 Taurolithocholic acid-d4-1 sodium Agonist / Unkown
HY-113920 Azumolene sodium Inhibitor / Unkown
HY-114691 R 59494 / Unkown
HY-114743 GS 283 Antagonist / Unkown
HY-114826 Prostaglandin E2-1-glyceryl ester Activator / Unkown
HY-114990 EMD 57439 Inhibitor / Unkown
HY-115493 TIQ-15 Antagonist / Unkown
HY-115767 (±)-1,2-Diolein Activator / Unkown
HY-115998 Carbonic anhydrase inhibitor 11 Inhibitor / Unkown
HY-115999 Carbonic anhydrase inhibitor 12 Inhibitor / Unkown
HY-116153 HUHS2002 / Unkown
HY-116330 Hyperforin / Unkown
HY-116429A 7(S)-Maresin 1 / Unkown
HY-116429S Maresin 1-d5 Inhibitor / Unkown
HY-116500A AH-1058 / Unkown
HY-117099 TMB-8 Antagonist / Unkown
HY-117578 KB 5666 / Unkown
HY-118387 AVE-0118 Inhibitor / Unkown
HY-119919 Clofenamide Inhibitor / Unkown
HY-120699 RO5488608 Modulator / Unkown
HY-120764 PF-46396 Inhibitor / Unkown
HY-120820 LY320954 Antagonist / Unkown
HY-121299 m-Chlorophenylbiguanide / Unkown
HY-12153 JNJ-1930942 Modulator / Unkown
HY-12155 JNJ-26990990 Inhibitor / Unkown
HY-121825 U-44069 Control / Unkown
HY-123434 PD-149164 Agonist / Unkown
HY-124176 L-6355 / Unkown
HY-12542S Dantrolene-13C3 Inhibitor ≥99.0% Unkown
HY-12596 JNJ-26489112 / Unkown
HY-126821 Fluo-3 / Unkown
HY-126821A Fluo-3 pentaammonium / Unkown
HY-129088 HUP30 99.68% Unkown
HY-129126 NC9 Inhibitor / Unkown
HY-129547 Fluo-3 pentapotassium / Unkown
HY-131001 DPNB-ABT594 Agonist / Unkown
HY-131012 GoSlo-SR-5-69 Activator / Unkown
HY-131041 Ned-K / Unkown
HY-131942 sFTX-3.3 Antagonist / Unkown
HY-132190 Hexanolamino PAF C-16 Antagonist / Unkown
HY-132239 5-Bromo-6-chloro-3-indolyl β-D-Galactopyranoside contains ca. 10% Ethyl Acetate / Unkown
HY-133596 12,14-Dichlorodehydroabietic acid / Unkown
HY-135110 Rp-8-Br-cGMPS sodium / Unkown
HY-135433 MAPTAM / Unkown
HY-135478 LY393615 Inhibitor / Unkown
HY-135601 Cinacalcet metabolite M4 / Unkown
HY-136189 UK-59811 hydrochloride Inhibitor / Unkown
HY-136283 DMNPE-4 AM-caged-calcium / Unkown
HY-136661 (-)-N6-Phenylisopropyl adenosine Agonist / Unkown
HY-136894 Rhod-5N / Unkown
HY-136980 Aspartylglutamate / Unkown
HY-138951 AY77 Agonist / Unkown
HY-138990 GK563 Inhibitor / Unkown
HY-139041 Palmitoylcholine chloride / Unkown
HY-139145 Etbicyphat Antagonist ≥98.0% Unkown
HY-139145S Etbicyphat-13C3 / Unkown
HY-142050 (R)-IDHP / Unkown
HY-142087 Beauverolide Ja Inhibitor / Unkown
HY-143460 CAXII-IN-1 Inhibitor / Unkown
HY-144222 NSC 828467 Inhibitor / Unkown
HY-144807 Carbonic anhydrase inhibitor 9 Inhibitor / Unkown
HY-145196 RTICBM-189 Modulator 99.73% Unkown
HY-145385 Coelenteramide / Unkown
HY-145542S Isovalerylcarnitine-d9 chloride / Unkown
HY-145900 S100A2-p53-IN-1 Inhibitor / Unkown
HY-146010 Carbonic anhydrase inhibitor 13 Inhibitor / Unkown
HY-146232 F 13714 Agonist / Unkown
HY-146252 hCAXII-IN-4 Inhibitor / Unkown
HY-146259 hCAIX/XII-IN-4 Inhibitor / Unkown
HY-146461 Anticancer agent 58 / Unkown
HY-146462 Anticancer agent 59 / Unkown
HY-14656S1 Diltiazem-(acetoxy-d3) (hydrochloride) Antagonist / Unkown
HY-146819 CAIX/CAXII-IN-1 / Unkown
HY-146982 hCAII-IN-1 Inhibitor / Unkown
HY-146983 hCAIX-IN-3 Inhibitor / Unkown
HY-147186 5,5'-Difluoro BAPTA / Unkown
HY-147377 N-Salicyloyltryptamine 96.37% Unkown
HY-147383 NS-8 Activator / Unkown
HY-149011 CA IX-IN-1 Inhibitor / Unkown
HY-149342 α-Glucosidase-IN-29 Inhibitor / Unkown
HY-149483 CVN417 Antagonist / Unkown
HY-150039 CCG-271423 Inhibitor / Unkown
HY-15018A SSR126768A free base Antagonist / Unkown
HY-150536 EP39 Inhibitor / Unkown
HY-150570 Carbonic anhydrase inhibitor 14 Inhibitor / Unkown
HY-150695 hCAIX/XII-IN-5 / Unkown
HY-150782 UNC-CA359 Inhibitor / Unkown
HY-151451 Cav 3.2 inhibitor 2 Inhibitor / Unkown
HY-151452 Cav 3.2 inhibitor 3 Inhibitor / Unkown
HY-151472 hCAIX/XII-IN-6 Inhibitor / Unkown
HY-151493 CAII-IN-1 Inhibitor / Unkown
HY-151494 CAII-IN-2 Inhibitor / Unkown
HY-151495 CAII-IN-3 Inhibitor / Unkown
HY-151547 MRS4719 Antagonist / Unkown
HY-151578 DPP IV/hCA II-IN-1 Inhibitor / Unkown
HY-151633 hCAIX-IN-14 Inhibitor / Unkown
HY-151917 Enpp/Carbonic anhydrase-IN-2 Inhibitor 99.76% Unkown
HY-152140 hCAII-IN-8 Inhibitor 99.41% Unkown
HY-15293 JTV-519 Inhibitor / Unkown
HY-155694 hCA/VEGFR-2-IN-1 Inhibitor / Unkown
HY-156013 CA inhibitor 2 Inhibitor / Unkown
HY-156082 RyRs activator 3 Inhibitor / Unkown
HY-156104 CaMKIIα-PHOTAC Degrader / Unkown
HY-156181 hCAIX/XII-IN-8 Inhibitor / Unkown
HY-157139 ALP/Carbonic anhydrase-IN-1 Inhibitor 99.90% Unkown
HY-158328A CA IX/VEGFR-2-IN-2 / Unkown
HY-15855 Fosbretabulin tromethamine / Unkown
HY-158779 Sulfane sulfur probe 4 / Unkown
HY-159122 CA IX-IN-2 / Unkown
HY-159861 Ionizable Lipid 4 / Unkown
HY-160962 SM1044 / Unkown
HY-160998 YM-344031 Antagonist / Unkown
HY-161143 Carbonic anhydrase/AChE-IN-2 Inhibitor / Unkown
HY-161388 NSCLC-IN-1 Inducer / Unkown
HY-162000 hCAIX/XII-IN-13 Inducer / Unkown
HY-162005 AChE-IN-48 Inhibitor / Unkown
HY-162063 hCAIX/XII-IN-9 Inhibitor / Unkown
HY-162280 PROTAC BTK Degrader-9 / Unkown
HY-162331 STING Degrader-1 Degrader / Unkown
HY-162344 Ir-CA Inducer / Unkown
HY-162374 ANO61 Inhibitor / Unkown
HY-162375 AF299 / Unkown
HY-162521 Antibacterial agent 215 Inhibitor / Unkown
HY-162526 HIV capsid modulator 2 Modulator / Unkown
HY-162774A GRP75-IN-1 hydrochloride Inducer / Unkown
HY-163116 Anti-inflammatory agent 67 Inhibitor / Unkown
HY-163117 Anti-inflammatory agent 68 Inhibitor / Unkown
HY-163380 CA/MAO-B-IN-1 Inhibitor 98.34% Unkown
HY-163795 GPR183-IN-1 Inhibitor / Unkown
HY-164682 AMD 3329 octahydrobromide Inhibitor / Unkown
HY-164684 Dichlorobenzamil Inhibitor / Unkown
HY-165473 Hexadecylphosphoserine Activator / Unkown
HY-167091 (Rac)-Beraprost / Unkown
HY-168320 N-Stearoyltyrosine Inhibitor / Unkown
HY-168603 AChE/CA I-IN-1 Inhibitor / Unkown
HY-168604 CA Ⅱ-IN-1 Inhibitor / Unkown
HY-169115A (Rac)-PD0299685 / Unkown
HY-169162 hBChE-IN-3 / Unkown
HY-169209 CA-M11 Inhibitor / Unkown
HY-169332 Piezo1 agonist 1-d2 / Unkown
HY-17404S Cilnidipine-d7 Inhibitor / Unkown
HY-19025 CV-159 Antagonist / Unkown
HY-19409 AJG049 Antagonist / Unkown
HY-19857 Sulcardine sulfate / Unkown
HY-70037S Cinacalcet-D3 Agonist / Unkown
HY-A0057AS2 Gabapentin-d4 hydrochloride Inhibitor / Unkown
HY-B0358AS Flunarizine-d8 dihydrochloride / Unkown
HY-B0588AS Brinzolamide-d5 hydrochloride / Unkown
HY-B0596S Taltirelin-13C,d3 / Unkown
HY-B0684S Iopamidol-d8 / Unkown
HY-B0782S1 Acetazolamide-13C2,d3 / Unkown
HY-B1221S Flufenamic acid-d4 / Unkown
HY-B1726 Phenacaine Inhibitor / Unkown
HY-B1837A β-Cyfluthrin Inhibitor 99.94% Unkown
HY-B1837AR β-Cyfluthrin (Standard) Inhibitor / Unkown
HY-B1873 Methoxychlor Inducer / Unkown
HY-D0121 INDO 1 / Unkown
HY-D0157 ZnAF-2 / Unkown
HY-D0861A EGTA tetrasodium / Unkown
HY-D1424 Coelenterazine hcp / Unkown
HY-D1501 Fura PE-3 potassium / Unkown
HY-D1608 BODIPY FL Thapsigargin Inhibitor / Unkown
HY-D1631 Calcium Green-5N AM / Unkown
HY-D1636 5-Nitro BAPTA / Unkown
HY-D1640 5',5-Difluoro BAPTA tetrapotassium / Unkown
HY-D1643 5,5'-Dinitro BAPTA AM / Unkown
HY-D1700 Mag-indo-1/AM / Unkown
HY-D1702 Mag-Fura-2 tetrapotassium / Unkown
HY-D1755 Fluo-3FF AM / Unkown
HY-E70197 Calpain-1 (pig) / Unkown
HY-E70197A Calpain-1, Human Erythrocyte Modulator / Unkown
HY-I0096S Indole-2-carboxylic acid-13C Inhibitor / Unkown
HY-N0043R Ginsenoside Rd (Standard) Inhibitor / Unkown
HY-N0081A (-)-Praeruptorin A Inhibitor / Unkown
HY-N0215S13 L-Phenylalanine-d1 Antagonist / Unkown
HY-N0215S6 DL-Phenylalanine-d5 hydrochloride Antagonist / Unkown
HY-N0215S9 L-Phenylalanine-13C9,15N,d8 Antagonist / Unkown
HY-N10512 Gangliotetraose / Unkown
HY-N10754 Aschantin Inhibitor / Unkown
HY-N11887 Linocinnamarin Inhibitor / Unkown
HY-N1228 Soyacerebroside I / Unkown
HY-N12726 Halociline Inhibitor / Unkown
HY-N3729 (-)-Denudatin B Inhibitor ≥97.0% Unkown
HY-N4237 Saikogenin D 98.95% Unkown
HY-N5123 α-L-Rhamnose / Unkown
HY-N7063R Nerol (Standard) / Unkown
HY-N7594 Senecionine acetate / Unkown
HY-N7848 Linoleamide 99.4% Unkown
HY-N7875 Celangulin / Unkown
HY-N9404 6-Benzoylheteratisine Inhibitor 99.66% Unkown
HY-P10316 CaMKI(299-320) Modulator / Unkown
HY-P10328 Vasoactive intestinal contractor Inhibitor / Unkown
HY-P10371 PKHB1 Activator / Unkown
HY-P10655 Caloxin 1C2 Inhibitor / Unkown
HY-P1075A CALP3 TFA Inhibitor / Unkown
HY-P1076 CALP2 Antagonist / Unkown
HY-P1077 CALP1 / Unkown
HY-P10773 CTP-amiodarone Inhibitor / Unkown
HY-P1080 ω-Agatoxin IVA Inhibitor / Unkown
HY-P10805 Capsid assembly inhibitor Inhibitor / Unkown
HY-P1247A Calcineurin autoinhibitory peptide TFA Inhibitor / Unkown
HY-P1250A RFRP-3(human) TFA Agonist / Unkown
HY-P1345 TLQP-21 Agonist / Unkown
HY-P1366A des-​Gln14-​Ghrelin TFA / Unkown
HY-P1437A Neuropeptide S(Mouse) TFA Agonist / Unkown
HY-P1479 Calmodulin-Dependent Protein Kinase II (290-309) / Unkown
HY-P1640 (Trp63,Trp64)​-​C3a(63-77) Agonist / Unkown
HY-P1805 Calmodulin Binding Peptide 1 Inhibitor / Unkown
HY-P1821 Myelin Basic Protein / Unkown
HY-P2847 Urocortin II, mouse Inhibitor / Unkown
HY-P3089 Dendrotoxin K Inhibitor / Unkown
HY-P3156 Syringomycin E Inhibitor / Unkown
HY-P3316 OSK-1 Inhibitor / Unkown
HY-P3679 Neuropeptide Y (1-24) (human) Activator / Unkown
HY-P3811 Autocamtide-3 / Unkown
HY-P3943 Calmodulin Dependent Protein Kinase Substrate Analog / Unkown
HY-P3944 Calmodulin Dependent Protein Kinase Substrate / Unkown
HY-P4397 (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin / Unkown
HY-P5154 Tamapin Antagonist / Unkown
HY-P5319 MCaE12A / Unkown
HY-P5422 Caloxin 3A1 Inhibitor / Unkown
HY-P5796 FS-2 Inhibitor / Unkown
HY-P5869 Kurtoxin / Unkown
HY-P5870 KTX-Sp2 Inhibitor / Unkown
HY-P6008 Myoregulin / Unkown
HY-P6008A Myoregulin TFA / Unkown
HY-P6013 wt hMLN Inhibitor / Unkown
HY-Q40876 BBT Modulator 99.71% Unkown
HY-RS01762 CA1 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01763 CA10 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01764 CA11 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01765 CA12 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01766 CA13 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01767 CA14 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01768 CA2 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01769 CA3 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01770 CA4 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01771 CA5A Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01772 CA5B Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01773 CA6 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01774 CA7 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01775 CA8 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01776 CA9 Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS01850 CALY Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS10524 Pik3ca Mouse Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS10525 Pik3ca Rat Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS10973 PPP1CA Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS11007 PPP2CA Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS11023 PPP3CA Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-U00026 Semotiadil recemate fumarate / Unkown
HY-W040028 Cartap hydrochloride Inducer / Unkown
HY-W339833 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium / Unkown
HY-W344044 Levomepromazine maleate / Unkown
HY-W424792A O-Desmethyl Brinzolamide hydrochloride Inhibitor / Unkown
HY-W748509 Pipernonaline / Unkown
HY-W749867 Ca(Ⅱ)-EDTA disodium dihydrate / Unkown
HY-W755295 Mabuterol hydrochloride Agonist / Unkown
HY-100981 MR-16728 hydrochloride / Unkown
HY-101669 TDN345 Antagonist / Unkown
HY-10167 Tecalcet Modulator / Unkown
HY-101685 Iganidipine Antagonist / Unkown
HY-101727 Nexopamil racemate / Unkown
HY-10341D Fasudil mesylate / Unkown
HY-108163 SB-237376 free base Antagonist / Unkown
HY-108496G Sphingosine-1-phosphate (GMP) Agonist / Unkown
HY-108984 BBMP / Unkown
HY-110091 TRPV1 antagonist 9 Antagonist / Unkown
HY-111198 YM-355179 fumarate / Unkown
HY-111527 PPZ2 / Unkown
HY-113658 ts-SA / Unkown
HY-113723 MRS2298 Antagonist / Unkown
HY-115231 ci-IP3/PM / Unkown
HY-116072 Antiarrhythmic agent-2 Inhibitor / Unkown
HY-116143 MAGL-IN-12 Inhibitor / Unkown
HY-116191 WJD008 Inhibitor / Unkown
HY-116723 CFMMC Antagonist / Unkown
HY-117055 Ro 18-3981 Inhibitor / Unkown
HY-117982 SKI2496 / Unkown
HY-120985 Araguspongin B / Unkown
HY-121366 Kadethrin Inhibitor / Unkown
HY-121516 CM-TPMF / Unkown
HY-121720 L 657925 Antagonist / Unkown
HY-121914 (2-Chlorophenyl)diphenylmethanol Inhibitor / Unkown
HY-129334 Macrocalin B Inhibitor / Unkown
HY-130358 PDDHV Activator / Unkown
HY-131764 2'-O-MB-cGMP sodium Inhibitor / Unkown
HY-133614 Dihydroisopimaric acid Activator / Unkown
HY-135110A Rp-8-Br-cGMPS / Unkown
HY-135478A LY393615 free base Inhibitor / Unkown
HY-137172 ETH 157 / Unkown
HY-141613A Dioleyl phosphatidylserine Activator / Unkown
HY-14477 UPF-1035 Inhibitor / Unkown
HY-147301B Resomelagon methanesulfonate Agonist / Unkown
HY-149779 RyR2 stabilizer-1 Modulator / Unkown
HY-152051S Mabuterol-d9 hydrochloride Agonist / Unkown
HY-154924 Thio-NADP / Unkown
HY-157321 hCAI/II-IN-7 Inhibitor / Unkown
HY-159870 E12CA1A3 / Unkown
HY-161848 TCP-MP-CA Inhibitor / Unkown
HY-163660 Carbonic anhydrase inhibitor 23 Inhibitor / Unkown
HY-167203 AJG049 free base Antagonist / Unkown
HY-169206 PF-3166 Inhibitor / Unkown
HY-19044 SKF 95601 / Unkown
HY-19062 SM-6586 / Unkown
HY-B0021S1 Doxifluridine-d3 Inhibitor / Unkown
HY-B0109AS Dorzolamide-d3 hydrochloride Inhibitor / Unkown
HY-B0109S Dorzolamide-d5 Inhibitor / Unkown
HY-B0632S2 Diltiazem-d4 Inhibitor / Unkown
HY-B2217D Calcium hydroxide, ACS, 95% Inhibitor / Unkown
HY-N12164 Linearmycin B Inhibitor / Unkown
HY-N7364S (E)-β-Farnesene-d6 Inhibitor / Unkown
HY-N7436S Methyl propyl disulfide-d3 / Unkown
HY-N8112 Polygalasaponin LII / Unkown
HY-N9484S Menthofuran-13C2 / Unkown
HY-W150752 Triphenylethylene / Unkown
HY-W288025 ALXR-agonist-6 Agonist / Unkown
HY-W414824 3β,7β-Dihydroxy-5-cholestenoic acid / Unkown
HY-W653978 Cinacalcet-d4 hydrochloride Agonist / Unkown
HY-W654243 Isovalerylcarnitine-d9-1 chloride Activator / Unkown
HY-132191 Pradimicin A Inhibitor / Unkown
HY-P0260 p2Ca / Unkown
HY-U00354 CP-060 Antagonist / Unkown

Orthologs Information

Species Symbol Source ID
Bos taurus CALY VGNC VGNC:26718
Macaca mulatta CALY VGNC VGNC:70575
Rattus norvegicus CALY RGD RGD:621719
Canis familiaris CALY VGNC VGNC:38676
Mus musculus CALY MGD MGI:1915816
Others CALY NCBI